6.07BMarket Cap-57989P/E (TTM)
54.730High52.170Low2.57MVolume53.330Open53.420Pre Close138.22MTurnover2.46%Turnover RatioLossP/E (Static)111.44MShares99.41052wk High6.66P/B5.71BFloat Cap14.02052wk Low--Dividend TTM104.78MShs Float99.410Historical High--Div YieldTTM4.79%Amplitude0.880Historical Low53.682Avg Price1Lot Size
Viking Therapeutics Stock Forum
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet